Recuvyra

RSS

Expired

This medicine's authorisation has expired

fentanyl
MedicineVeterinaryExpired

Estonian is available via eTranslation, the European Commission's machine translation service.

Translate to Estonian | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Recuvyra has expired following the marketing-authorisation holder’s decision not to apply for a renewal.

български (BG) (568.84 KB - PDF)

Vaata

español (ES) (537.02 KB - PDF)

Vaata

čeština (CS) (573.8 KB - PDF)

Vaata

dansk (DA) (511.6 KB - PDF)

Vaata

Deutsch (DE) (515.35 KB - PDF)

Vaata

eesti (ET) (539.37 KB - PDF)

Vaata

ελληνικά (EL) (586.2 KB - PDF)

Vaata

français (FR) (538.28 KB - PDF)

Vaata

italiano (IT) (535.2 KB - PDF)

Vaata

latviešu (LV) (569.81 KB - PDF)

Vaata

lietuvių (LT) (534.12 KB - PDF)

Vaata

magyar (HU) (548.34 KB - PDF)

Vaata

Malti (MT) (576.33 KB - PDF)

Vaata

Nederlands (NL) (513.44 KB - PDF)

Vaata

polski (PL) (552.75 KB - PDF)

Vaata

português (PT) (535.52 KB - PDF)

Vaata

română (RO) (533.59 KB - PDF)

Vaata

slovenčina (SK) (570.05 KB - PDF)

Vaata

slovenščina (SL) (564.24 KB - PDF)

Vaata

suomi (FI) (533.75 KB - PDF)

Vaata

svenska (SV) (535.74 KB - PDF)

Vaata

Product information

български (BG) (1.46 MB - PDF)

Vaata

español (ES) (876.92 KB - PDF)

Vaata

čeština (CS) (1.18 MB - PDF)

Vaata

dansk (DA) (873.6 KB - PDF)

Vaata

Deutsch (DE) (889.37 KB - PDF)

Vaata

eesti (ET) (830.81 KB - PDF)

Vaata

ελληνικά (EL) (1.51 MB - PDF)

Vaata

français (FR) (864.23 KB - PDF)

Vaata

hrvatski (HR) (875.28 KB - PDF)

Vaata

italiano (IT) (859.62 KB - PDF)

Vaata

latviešu (LV) (1.25 MB - PDF)

Vaata

lietuvių (LT) (810.52 KB - PDF)

Vaata

magyar (HU) (1.25 MB - PDF)

Vaata

Malti (MT) (1.26 MB - PDF)

Vaata

Nederlands (NL) (855.45 KB - PDF)

Vaata

polski (PL) (1.23 MB - PDF)

Vaata

português (PT) (838.3 KB - PDF)

Vaata

română (RO) (1 MB - PDF)

Vaata

slovenčina (SK) (1.18 MB - PDF)

Vaata

slovenščina (SL) (1.13 MB - PDF)

Vaata

suomi (FI) (858.03 KB - PDF)

Vaata

svenska (SV) (851.7 KB - PDF)

Vaata

Íslenska (IS) (879.42 KB - PDF)

Vaata

norsk (NO) (836.37 KB - PDF)

Vaata
Latest procedure affecting product information:IB/0009/G
13/10/2016

български (BG) (498.29 KB - PDF)

Vaata

español (ES) (458.29 KB - PDF)

Vaata

čeština (CS) (487.32 KB - PDF)

Vaata

dansk (DA) (460.34 KB - PDF)

Vaata

Deutsch (DE) (460.75 KB - PDF)

Vaata

eesti (ET) (460.29 KB - PDF)

Vaata

ελληνικά (EL) (495.78 KB - PDF)

Vaata

français (FR) (460.31 KB - PDF)

Vaata

hrvatski (HR) (471.53 KB - PDF)

Vaata

italiano (IT) (460.57 KB - PDF)

Vaata

latviešu (LV) (491.15 KB - PDF)

Vaata

lietuvių (LT) (475.45 KB - PDF)

Vaata

magyar (HU) (485.61 KB - PDF)

Vaata

Malti (MT) (488.27 KB - PDF)

Vaata

Nederlands (NL) (458.26 KB - PDF)

Vaata

polski (PL) (485.72 KB - PDF)

Vaata

português (PT) (460.24 KB - PDF)

Vaata

română (RO) (474.03 KB - PDF)

Vaata

slovenčina (SK) (487.71 KB - PDF)

Vaata

slovenščina (SL) (477.71 KB - PDF)

Vaata

suomi (FI) (458.28 KB - PDF)

Vaata

svenska (SV) (460.23 KB - PDF)

Vaata

Íslenska (IS) (457.47 KB - PDF)

Vaata

norsk (NO) (461.18 KB - PDF)

Vaata

Product details

Name of medicine
Recuvyra
Active substance
fentanyl
International non-proprietary name (INN) or common name
fentanyl
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QN02AB03

Pharmacotherapeutic group

Nervous system

Therapeutic indication

For the control of pain associated with orthopaedic and soft tissue surgery in dogs.

Authorisation details

EMA product number
EMEA/V/C/002239
Marketing authorisation holder
Eli Lilly and Company Limited 

Eli Lilly and Company Limited
Lilly House
Priestley Road
Basingstoke
Hampshire RG24 9NL
United Kingdom

Marketing authorisation issued
06/10/2011
Expiry of marketing authorisation
13/10/2016
Revision
4

Assessment history

This page was last updated on

Share this page